The Glaucoma Book A Practical, Evidence-Based Approach to Patient Care

The Basics -- Glaucoma in the Twenty-First Century -- An Evidence-Based Approach to Glaucoma Care -- Glaucoma Risk Factors: Intraocular Pressure -- Glaucoma Risk Factors: Fluctuations in Intraocular Pressure -- Glaucoma is a 24/7 Disease -- Continuous Monitoring of Intraocular Pressure -- Aqueous Veins and Open Angle Glaucoma -- Glaucoma Risk Factors: The Cornea -- Glaucoma Risk Factors: Family History – The Genetics of Glaucoma -- Glaucoma Risk Factors: Ethnicity and Glaucoma -- Glaucoma Risk Factors: Ocular Blood Flow -- Glaucoma Risk Factors: Sleep Apnea and Glaucoma -- Evaluating Ophthalmic Literature -- Indications for Therapy -- The Examination -- Clinical Examination of the Optic Nerve -- Clinical Cupping: Laminar and Prelaminar Components -- Disc Hemorrhages and Glaucoma -- Some Lessons from the Disc Appearance in the Open Angle Glaucomas -- Evaluating the Optic Nerve for Glaucomatous Progression -- Digital Imaging of the Optic Nerve -- Clinical Utility of Computerized Optic Nerve Analysis -- Photography of the Optic Nerve -- Detecting Functional Changes in the Patient’s Vision: Visual Field Analysis -- Using Electroretinography for Glaucoma Diagnosis -- Glaucomatous Versus Nonglaucomatous Visual Loss: The Neuro-Ophthalmic Perspective -- Gonioscopy -- Beyond Gonioscopy: Digital Imaging of the Anterior Segment -- Office Examination of the Glaucoma Patient -- Glaucoma and Driving -- Electronic Medical Records in the Glaucoma Practice -- Advanced Glaucoma and Low Vision: Evaluation and Treatment -- Glaucoma and Medical Insurance: Billing and Coding Issues -- Medical Legal Considerations When Treating Glaucoma Patients -- The Glaucomas -- Primary Open Angle Glaucoma -- Normal Pressure Glaucoma -- Primary and Secondary Angle-Closure Glaucomas -- Malignant Glaucoma (Posterior Aqueous Diversion Syndrome) -- Pigmentary Dispersion Syndrome and Glaucoma -- Exfoliation Syndrome and Glaucoma -- Neovascular Glaucoma -- Inflammatory Disease and Glaucoma -- Posner–Schlossman Syndrome -- Fuchs’ Uveitis Syndrome and Glaucoma -- Herpes Simplex Related Glaucoma -- Herpes Zoster Related Glaucoma -- Iridocorneal Endothelial Syndrome and Glaucoma -- Ghost Cell Glaucoma -- Fuchs’ Endothelial Dystrophy and Glaucoma -- Ocular Trauma and Glaucoma -- Infantile, Childhood, and Juvenile Glaucomas -- The Medical Treatment -- Medications Used to Treat Glaucoma -- Choosing Adjunctive Glaucoma Therapy -- Monocular Drug Trials for Glaucoma Therapy in the Community Setting -- Neuroprotection of Retinal Ganglion Cells -- Compliance and Adherence: Lifelong Therapy for Glaucoma -- Alternative and Non-traditional Treatments of Glaucoma -- Intravitreal Steroids and Glaucoma -- Pregnancy and Glaucoma -- Systemic Side Effects of Glaucoma Medications -- Systemic Diseases and Glaucoma -- The Surgical Treatment -- Laser Therapies: Iridotomy, Iridoplasty, and Trabeculoplasty -- Laser Iridoplasty Techniques for Narrow Angles and Plateau Iris Syndrome -- Laser Therapies: Cyclodestructive Procedures -- Laser Therapies: Newer Technologies -- Incisional Therapies: Trabeculectomy Surgery -- Incisional Therapies: Trabeculotomy Surgery in Adults -- Incisional Therapies: Canaloplasty and New Implant Devices -- Incisional Therapies: Shunts and Valved Implants -- Incisional Therapies: What’s on the Horizon? -- Incisional Therapies: Complications of Glaucoma Surgery -- Amniotic Membrane Grafts for Glaucoma Surgery -- Treating Choroidal Effusions After Glaucoma Surgery -- Cyclodialysis Clefts: Surgical and Traumatic -- Epithelial Downgrowth -- Penetrating Keratoplasty and Glaucoma -- Descemet’s Stripping Endothelial Keratoplasty (DSEK) and Glaucoma -- Cataract and Glaucoma Surgery -- Cataract Extraction as Treatment for Acute and Chronic Angle Closure Glaucomas -- Refractive Surgery and Glaucoma -- Glaucoma after Retinal Surgery -- The Future -- Immunology and Glaucoma -- How the Revolution in Cell Biology Will Affect Glaucoma: Biomarkers -- CD44 and Primary Open Angle Glaucoma -- Stem Cells and Glaucoma -- Cytoskeletal Active Agents for Glaucoma Therapy -- The Drug Discovery Process: How Do New Glaucoma Medications Come to Market? -- Glaucoma Clinical Research in the Community Setting -- Future Glaucoma Medical Therapies: What’s in the Pipeline? -- Anecortave Acetate: A New Approach for the Medical Treatment of Glaucoma -- Future Glaucoma Instrumentation: Diagnostic and Therapeutic -- What Really Causes Glaucoma? -- The Glaucoma Book: What Do We Know Now, What Do We Need to Know About Glaucoma?.